TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,388,000 | -15.6% | 126,266 | -0.8% | 0.29% | -10.8% |
| Q2 2021 | $9,935,000 | -43.4% | 127,345 | -31.4% | 0.32% | -44.3% |
| Q1 2021 | $17,562,000 | -57.1% | 185,665 | -44.8% | 0.58% | -59.1% |
| Q4 2020 | $40,963,000 | +66.0% | 336,173 | +19.0% | 1.42% | +30.3% |
| Q3 2020 | $24,674,000 | +95.4% | 282,440 | +44.5% | 1.09% | +83.6% |
| Q2 2020 | $12,628,000 | +488.2% | 195,503 | +306.6% | 0.60% | +341.5% |
| Q1 2020 | $2,147,000 | – | 48,083 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |